Literature DB >> 15286387

Animal models of insulin-dependent diabetes.

Edwin Liu1, Liping Yu, Hiroaki Moriyama, George S Eisenbarth.   

Abstract

Animal models have contributed enormously to study in the field of type 1 diabetes. Perhaps the most intensively studied model is the nonobese diabetic (NOD) mouse, which develops an autoimmune-mediated spontaneous diabetes associated with the development of insulin autoantibodies and insulitis. Accurate measurement of antiislet autoantibodies by radioassay and detection of antigen-specific T cells using major histocompatibility complex tetramers are possible. Various strategies have been developed in preventing diabetes in animal models; a peptide-induced model of type 1 diabetes has been described. Finally, the development of peptide vaccines is hampered by the risk of anaphylaxis in both mouse and humans. In this chapter, methods and strategies to measure antiinsulin autoantibodies, to detect antigen-specific T cells by tetramer analysis, and to prevent diabetes using peptide vaccines are discussed. Along with these topics, a protocol of peptide-induced diabetes and peptide vaccine-induced anaphylaxis are described, serving as a reminder of the potential dangers that could exist in human trials. In summary, animal models have become necessary in the study of type 1 diabetes and provide researchers important tools to conduct studies that could not otherwise be performed in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286387     DOI: 10.1385/1-59259-805-6:195

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  8 in total

Review 1.  2011 Update: antigen-specific therapy in type 1 diabetes.

Authors:  Aaron W Michels; Matthias von Herrath
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-08       Impact factor: 3.243

Review 2.  Autoimmune polyglandular syndromes.

Authors:  Aaron W Michels; Peter A Gottlieb
Journal:  Nat Rev Endocrinol       Date:  2010-03-23       Impact factor: 43.330

3.  Proteomic changes associated with diabetes in the BB-DP rat.

Authors:  D Thor Johnson; Robert A Harris; Stephanie French; Angel Aponte; Robert S Balaban
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-04       Impact factor: 4.310

4.  Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.

Authors:  Damien Bresson; Matthias von Herrath
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 17.152

5.  LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.

Authors:  Daniel H Zimmerman; Harold Steiner; Roy Carmabula; Eyal Talor; Ken S Rosenthal
Journal:  J Vaccines Vaccin       Date:  2012-09-20

Review 6.  Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes.

Authors:  Maki Nakayama; Kimberly M Simmons; Aaron W Michels
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

7.  Targeting the trimolecular complex: the pathway towards type 1 diabetes prevention.

Authors:  Aaron W Michels
Journal:  Diabetes Technol Ther       Date:  2013-06       Impact factor: 6.118

8.  Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.

Authors:  Shi-Wu Li; Vijay Koya; Yi Li; William Donelan; Peng Lin; Westley H Reeves; Li-Jun Yang
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.